MegaPro Biomedical was invited to “The Third China BioMed Innovation and Investment Conference” hosted by PhIRDA

Dr. Jassy Wang will represent MegaPro Biomedical in The Third China BioMed Innovation and Investment Conference hosted by PhIRDA in Suzhou. In addition to interacting with the key pharmaceutical, new drug, and medical equipment companies as well as investment organizations in China, she will conduct a special roadshow between 4.40pm and 5 pm on September 19, 2018. The theme of the roadshow is “a kind of nanomedicine that can treat iron deficiency anemia and be used as MRI contrast agent” and centers around the successful development of two indications from superparamagnetic iron oxide nanoparticle. The two indications are MPB-1514 iron supplement for iron deficiency anemia and MPB-1523 contrast agent for hepatocellular carcinoma, and both have obtained the approval from the US FDA for Phase II of clinical trials.